Delta-Fly Pharma, Inc. [4598.T]
TOKYO, May 01 (Pulse News Wire) – Delta-fly Pharma,inc. (4598.T) reported the exercise status of its 11th warrant issue with adjustment clauses for the month of April.
The warrants were issued to Macquarie Bank Limited on February 02, 2026. In April, 174 out of 186 outstanding warrants were exercised, representing 99.47% of the total issuance. As of the end of March, there were 186 unexercised warrants, which decreased to 174 by the end of April. Exercise details for April included: - On April 3, 200 shares were delivered against 174 warrants. - On April 6, 300 shares were delivered against 170 warrants.
- On April 14, 200 shares were delivered against 175 warrants. - On April 15, 200 shares were delivered against 177 warrants. - On April 16, 300 shares were delivered against 180 warrants. - On April 17, 200 shares were delivered against 181 warrants. The company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Listing Regulations Article 434 and the Japan Securities Dealers Association's Rules Governing Third Party Allotment Issues, maintaining an exercise ratio of 9.96%.
🟢 Confidence: High AI-translated content.